The technology for manufacturing antiparasitic preparations. 5. The development of a technology for producing the anthelmintic triclonate and the evaluation of its therapeutic efficacy in monieziasis

A procedure has been developed to manufacture the anthelminthic Triclonate. The agent was tested for the treatment of sheep's natural monieziasis infection and it was found to have a high activity.

Saved in:
Bibliographic Details
Published inMeditsinskaia parazitologiia i parazitarnye bolezni no. 1; p. 27
Main Authors Mikhaĭlitsyn, F S, Petrov, Iu F, Kozyreva, N P, Bol'shakova, A Iu, Golovkina, L P, Lebedeva, M N, Lychko, N D
Format Journal Article
LanguageRussian
Published Russia (Federation) 01.01.1996
Subjects
Animals
Anticestodal Agents - analysis
Anticestodal Agents - chemical synthesis
Anticestodal Agents - therapeutic use
Anticestodal Agents - toxicity
Drug Evaluation, Preclinical - veterinary
Mice
Monieziasis - drug therapy
Niclosamide - therapeutic use
Sheep
Sheep Diseases - drug therapy
Spectrophotometry, Infrared
Technology, Pharmaceutical
Online AccessGet more information

Cover

More Information
Summary:A procedure has been developed to manufacture the anthelminthic Triclonate. The agent was tested for the treatment of sheep's natural monieziasis infection and it was found to have a high activity.
ISSN:0025-8326